Net Cash Provided by (Used in) Operating Activities |
-1.83M |
USD |
-12.3% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
840K |
USD |
-77.7% |
Q1 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-101K |
USD |
|
Q1 2022 |
Q1 2023 |
Common Stock, Shares Authorized |
230M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
136M |
shares |
+0.67% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-786K |
USD |
-139% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6.34M |
USD |
-27.3% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
37.8M |
USD |
+14.7% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
32.2M |
USD |
+20.7% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
2M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
110M |
USD |
+7.16% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
9.61K |
USD |
-10.3% |
Q1 2023 |
Q1 2023 |
Share-based Payment Arrangement, Expense |
395K |
USD |
-79.3% |
Q2 2024 |
Q2 2024 |
Interest Expense |
1.01M |
USD |
-0.67% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |